Cipta Sarana Medika Tbk. vs Reksa Dana Indeks Cipta ETF Index LQ45 — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 22.32M 24h volume), while Reksa Dana Indeks Cipta ETF Index LQ45 trades at Rp66 (market cap 8.24B, 300 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 19.5× Reksa Dana Indeks Cipta ETF Index LQ45's market cap, and Cipta Sarana Medika Tbk. is more actively traded (22.32M versus 300). Which is the better fit depends on your goals.
| DKHH | XCLQ | |
|---|---|---|
Market Cap | 160.67B | 8.24B |
Volume | 22.32M | 300 |
Lot | 223.23K | 3 |
Turnover | 1.45B | 19.9K |
Average Price | 65.12 | 66.33 |
Value | 1.45B | 19.9K |
Indicative Equilibrium Price | 64 | — |
Indicative Equilibrium Volume | 1.35K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →